Bombay HC refuses to hear PIL seeking uniform rate of Covid-19 vaccines

The Bombay High Court on Thursday refused to hear a PIL seeking a direction to the Serum Institute of India and the Bharat Biotech to sell their COVID-19 vaccines at a uniform rate of Rs 150 (plus GST) per dose.
The public interest litigation (PIL), filed last week by Mumbai-based advocate Fayzan Khan and three law students, had challenged the different rates of COVID-19 vaccines for the Centre and state governments.
The plea was mentioned on Thursday by the petitioner's advocate, Vivek Shukla, before a division bench of Chief Justice Dipankar Datta and Justice G S Kulkarni, seeking urgent hearing.
The HC, however, said the petition should have been filed before the Supreme Court which, while taking up suo motu (on its own) cognisance of matters pertaining to COVID-19, had said it would hear all pan-India issues.

Related Keywords

Mumbai ,Maharashtra ,India ,Bombay ,Bharat ,Justice Dipankar Datta ,Fayzan Khan ,Justicegs Kulkarni ,Vivek Shukla ,Supreme Court ,Bombay High Court On ,Central Drugs Laboratory ,Serum Institute Of India ,Bombay High Court ,Serum Institute ,Bharat Biotech ,Chief Justice Dipankar Datta ,Public Image Ltd ,Soil ,Usical Groups ,Musicians ,British Musicians ,Anjali Damania ,Vanashakti ,Bio Therapeutic Drugs ,Harmaceuticals Nec ,Chief Justice ,Advocate ,Gs Kulkarni ,Bombay High ,மும்பை ,மகாராஷ்டிரா ,இந்தியா ,குண்டு ,பாரத் ,நீதி டிபங்கர் தத்தா ,விவேக் சுக்லா ,உச்ச நீதிமன்றம் ,குண்டு உயர் நீதிமன்றம் ஆன் ,மைய மருந்துகள் ஆய்வகம் ,சீரம் நிறுவனம் ஆஃப் இந்தியா ,குண்டு உயர் நீதிமன்றம் ,சீரம் நிறுவனம் ,பாரத் பயோடெக் ,தலைமை நீதி டிபங்கர் தத்தா ,பொது படம் லிமிடெட் ,நான் L ,